BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 38686798)

  • 1. Prognostic impact of muscle mass loss in elderly patients with oesophageal cancer receiving neoadjuvant chemoradiation therapy.
    Jang JY; Oh D; Noh JM; Sun JM; Kim HK; Shim YM
    J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):1167-1176. PubMed ID: 38613258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of body mass index in small-cell lung cancer: Exploring the relationship with skeletal muscle status.
    Kwon YJ; Yoon YC; Kim HS; Cha MJ; Park S; Lee JH
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2939-2947. PubMed ID: 37986687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative chemotherapy versus adjuvant chemotherapy in patients with resectable gastric cancer: A systematic review with meta-analysis.
    Wei C; Du X; Hu J; Dong Y; Chen Y; Cao B
    Crit Rev Oncol Hematol; 2024 Jun; 198():104082. PubMed ID: 37532103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of body composition, grip strength, and physical performance on clinical outcomes for locally advanced gastric cancer during neoadjuvant chemotherapy: A prospective cohort study.
    Zhou D; Zuo J; Zeng C; Zhang L; Gao X; Li G; Wang X
    Nutrition; 2024 Apr; 125():112472. PubMed ID: 38810532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal muscle loss after total gastrectomy, exacerbated by adjuvant chemotherapy.
    Yamaoka Y; Fujitani K; Tsujinaka T; Yamamoto K; Hirao M; Sekimoto M
    Gastric Cancer; 2015 Apr; 18(2):382-9. PubMed ID: 24715254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of skeletal muscle mass in patients with unresectable gastric cancer who received palliative first-line chemotherapy based on 5-fluorouracil.
    Matsunaga T; Saito H; Miyauchi W; Shishido Y; Miyatani K; Morimoto M; Murakami Y; Hanaki T; Kihara K; Yamamoto M; Tokuyasu N; Takano S; Sakamoto T; Hasegawa T; Fujiwara Y
    BMC Cancer; 2021 Nov; 21(1):1219. PubMed ID: 34774016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy.
    Dijksterhuis WPM; Pruijt MJ; van der Woude SO; Klaassen R; Kurk SA; van Oijen MGH; van Laarhoven HWM
    J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):199-206. PubMed ID: 30666831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact on postoperative complications of changes in skeletal muscle mass during neoadjuvant chemotherapy for gastro-oesophageal cancer.
    den Boer RB; Jones KI; Ash S; van Boxel GI; Gillies RS; O'Donnell T; Ruurda JP; Sgromo B; Silva MA; Maynard ND
    BJS Open; 2020 Oct; 4(5):847-854. PubMed ID: 32841538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal muscle mass correlates with increased toxicity during neoadjuvant radiochemotherapy in locally advanced esophageal cancer: A SAKK 75/08 substudy.
    Panje CM; Höng L; Hayoz S; Baracos VE; Herrmann E; Garcia Schüler H; Meier UR; Henke G; Schacher S; Hawle H; Gérard MA; Ruhstaller T; Plasswilm L;
    Radiat Oncol; 2019 Sep; 14(1):166. PubMed ID: 31511012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of adjuvant and neoadjuvant therapy for resectable gastric cancer in the East.
    Fujitani K
    Dig Surg; 2013; 30(2):119-29. PubMed ID: 23867588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of skeletal muscle mass change during the neoadjuvant chemotherapy period in patients with gastric cancer: An ancillary study of JCOG1002.
    Sato R; Tokunaga M; Mizusawa J; Sato Y; Ito S; Takahari D; Sano T; Onaya H; Yoshikawa T; Boku N; Terashima M
    World J Surg; 2024 Jan; 48(1):163-174. PubMed ID: 38686798
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.